Team Melcangi Launches Milano Project to Advance PFS Research
The PFS Foundation, in collaboration with Professor Roberto Cosimo Melcangi from the University of Milano, has launched the groundbreaking “Milano Project.” This initiative aims to accelerate research on Post-Finasteride Syndrome (PFS) with the goal of moving from animal models to human clinical trials. The Milano Project seeks to identify potential therapies for PFS, with allopregnanolone as the initial therapeutic target, and is set to be completed by the end of 2026.
Professor Melcangi and his team have been investigating PFS for over a decade, and this project represents a critical step forward in understanding the condition. The project will focus on speeding up current investigations, launching new studies to establish biomarkers, and compiling comprehensive molecular and genetic data. These efforts are aimed at laying the groundwork for future clinical trials in human patients, which would be a significant milestone in PFS research.
To support this crucial work, the PFS Foundation is seeking donations to help fund the remaining budget of $270,000. Contributions can be made directly through the PFS Foundation or through affiliated charities like SIDEfxHUB.
Donate Through SIDEfxHUB and Benefit from Gift Aid
UK citizens have a unique opportunity to amplify their impact through Gift Aid, which adds 25% to your donation at no extra cost. When donating to the Milano Project through SIDEfxHUB, be sure to claim Gift Aid to maximize your contribution. This is an excellent way for UK donors to support critical PFS research while making their donations go even further.
For more details on the Milano Project and how to donate, please visit:
Learn more about PFS & PSSD
What is Post-Finasteride Syndrome?
PFS (Post-Finasteride Syndrome) is a complex and life-altering condition caused by the drug Finasteride (also marketed as Propecia) and other 5ar inhibitors. It affects physical, mental, and sexual health, leaving patients to suffer without adequate support, recognition or treatment.
What is Post-SSRI Sexual Dysfunction?
PSSD (Post-SSRI Sexual Dysfunction) is a serious and debilitating condition associated with the use of selective serotonin reuptake inhibitors (SSRIs) and similar drugs. It affects mental, physical, and sexual well-being, leaving many patients to suffer without sufficient support, recognition, or effective treatment.
